Communiqués Waters Corporation

Actions

WAT

US9418481035

Equipement et technologie médicale avancés

Marché Fermé - NYSE Autres places de cotation 22:00:02 05/08/2026			Varia. 5j.	Varia. 1 janv.
400,00 ^USD	+0,99%		+5,41%	+5,31%

13:06	Becton Dickinson relève le bas de sa fourchette de prévision de bénéfice annuel grâce à la solidité de ses dispositifs d'administration de médicaments	RE
05/08	WATERS CORPORATION : Opinion positive de Wells Fargo Securities	ZM

Communiqués

04/08	Waters: Q2 Earnings Snapshot	AQ
04/08	Waters Corporation (NYSE: WAT) Reports Second Quarter 2026 Financial Results	PR
27/07	Waters Launches Industry's Most Sensitive and Robust Clinical IVD System with Xevo TQ Absolute XR IVD Mass Spectrometer	PR
27/07	Waters Launches Industry's Most Sensitive and Robust Clinical IVD System with Xevo TQ Absolute XR IVD Mass Spectrometer	AQ
02/07	Waters Corporation Schedules Second Quarter 2026 Earnings Conference Call	PR
24/06	IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine	PR
24/06	IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine	AQ
24/06	HighRes(R) and Waters Collaborate to Advance Drug Discovery through Robotic Automation	AQ
09/06	Waters Launches Coin Cell Differential Scanning Calorimeter (DSC) to Advance Battery Safety with Integrated Thermal, Evolved Gas, and Electrochemical Analysis	PR
09/06	Waters Launches Coin Cell Differential Scanning Calorimeter (DSC) to Advance Battery Safety with Integrated Thermal, Evolved Gas, and Electrochemical Analysis	AQ
08/06	Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis	PR
08/06	Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis	AQ
03/06	Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics	PR
03/06	Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics	AQ
01/06	Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research	PR
01/06	Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics	PR
01/06	Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics	AQ
01/06	Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research	AQ
18/05	Waters Corporation to Present at the Jefferies Global Healthcare Conference	PR
12/05	D. Mass. Patent Litigation Update: March 2026	AQ
05/05	Waters: Q1 Earnings Snapshot	AQ
05/05	Waters : First Quarter 2026 Non-GAAP Addendum	PU
05/05	Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results	PR
20/04	Waters Corporation Schedules First Quarter 2026 Earnings Conference Call	PR
14/04	Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules	PR